EXHIBIT 1.1

                               THE TIMKEN COMPANY

                              (an Ohio corporation)

                        12,895,973 Shares of Common Stock

                               PURCHASE AGREEMENT

Dated:  October 15, 2003



                                Table of Contents

PURCHASE AGREEMENT


                                                                                      
SECTION 1. Representations and Warranties...........................................      3
         (a)    Representations and Warranties by the Company.......................      3
                (i)     Compliance with Registration Requirements...................      3
                (ii)    Incorporated Documents......................................      3
                (iii)   Independent Accountants.....................................      4
                (iv)    Financial Statements........................................      4
                (v)     No Material Adverse Change in Business......................      4
                (vi)    Good Standing of the Company................................      5
                (vii)   Good Standing of Subsidiaries...............................      5
                (viii)  Venture Entities............................................      5
                (ix)    Authorization of Agreement..................................      5
                (x)     Authorization and Description of Securities.................      6
                (xi)    Absence of Defaults and Conflicts...........................      6
                (xii)   Distributions and Dividend Payments.........................      6
                (xiii)  Internal Controls...........................................      7
                (xiv)   Absence of Labor Dispute....................................      7
                (xv)    Absence of Proceedings......................................      7
                (xvi)   Possession of Intellectual Property.........................      7
                (xvii)  Absence of Further Requirements.............................      8
                (xviii) Possession of Licenses and Permits..........................      8
                (xix)   Title to Property...........................................      8
                (xx)    Investment Company Act......................................      8
                (xxi)   Registration Rights.........................................      8
                (xxii)  Environmental Laws..........................................      9
         (b)    Representations and Warranties by the Selling Stockholder...........      9
                (i)     Information Furnished by the Selling Stockholder............      9
                (ii)    Authorization of Agreements.................................      9
                (iii)   Good and Marketable Title...................................     10
                (iv)    Absence of Manipulation.....................................     10
                (v)     Absence of Further Requirements.............................     10
                (vi)    Restriction on Sale of Securities...........................     10
                (vii)   IR Shares Suitable for Transfer.............................     11
                (viii)  No Association with NASD....................................     11
                (ix)    Selling Stockholder Information.............................     11
         (c)    Officer's Certificates..............................................     11

SECTION 2. Sale and Delivery to Underwriter; Closing................................     11
         (a)    The Securities......................................................     11
         (b)    Payment.............................................................     11
         (c)    Denominations; Registration.........................................     12

SECTION 3. Covenants of the Company.................................................     12





                                                                                      
SECTION 4. Payment of Expenses......................................................     15
         (a)    Expenses of the Company.............................................     15
         (b)    Expenses of the Selling Stockholder.................................     15
         (c)    Termination of Agreement............................................     15

SECTION 5. Conditions of Underwriter's Obligations..................................     16

SECTION 6. Indemnification..........................................................     18
         (a)    Indemnification of the Underwriter and the Selling Stockholder
                by the Company......................................................     18
         (b)    Indemnification of the Company, the Selling Stockholder, Directors
                and Officers by the Underwriter.....................................     20
         (c)    Indemnification of the Company, the Underwriter, Directors and
                Officers by the Selling Stockholder.................................     20
         (d)    Actions Against Parties; Notification...............................     20
         (e)    Settlement Without Consent if Failure to Reimburse..................     21
         (f)    Acknowledgement.....................................................     21

SECTION 7. Contribution.............................................................     21

SECTION 8. Representations, Warranties and Agreements to Survive Delivery...........     23

SECTION 9. Termination of Agreement.................................................     23
         (a)    Termination; General................................................     23
         (b)    Liabilities.........................................................     23

SECTION 10. Notices.................................................................     23

SECTION 11. Parties.................................................................     24

SECTION 12. GOVERNING LAW AND TIME..................................................     24

SECTION 13. Effect of Headings......................................................     24





                                                                                 
SCHEDULES

         Schedule A - Pricing Information.......................................    Sch A-1
         Schedule B - List of Subsidiaries......................................    Sch B-1
         Schedule C - List of Persons and Entities Subject to Lock-up...........    Sch C-1

EXHIBITS

         Exhibit A - Form of Opinion of Company's Counsel.......................        A-1
         Exhibit B - Form of Letter of Company's Counsel........................        B-1
         Exhibit C - Form of Opinion of Company's In-house Counsel..............        C-1
         Exhibit D - Form of Opinion of Selling Stockholder's Counsel...........        D-1
         Exhibit E - Form of Lock-up Agreement..................................        E-1




                               THE TIMKEN COMPANY
                              (an Ohio corporation)

                        12,895,973 Shares of Common Stock
                                 (No Par Value)

                               PURCHASE AGREEMENT

                                                                October 15, 2003

Morgan Stanley & Co. Incorporated
1585 Broadway
New York, New York 10036

Ladies and Gentlemen:

         The Timken Company, an Ohio corporation (the "Company"), and
Ingersoll-Rand Company, a New Jersey corporation (the "Selling Stockholder"),
confirm their respective agreements with Morgan Stanley & Co. Incorporated (the
"Underwriter") with respect to the issue and sale by the Company and the
purchase by the Underwriter of 3,500,000 shares (the "Company Shares") of Common
Stock, without par value, of the Company ("Common Stock") and the sale by the
Selling Stockholder and the purchase by the Underwriter of 9,395,973 shares (the
"IR Shares") of Common Stock. The Company Shares and the IR Shares are
hereinafter referred to collectively as the "Securities."

         The Company and the Selling Stockholder understand that the Underwriter
proposes to make a public offering of the Securities as soon as the Underwriter
deems advisable after this Agreement has been executed and delivered.

         The Company has filed with the Securities and Exchange Commission (the
"Commission") (i) a shelf registration statement on Form S-3 (No. 333-100731)
covering the registration of the Company Shares under the Securities Act of
1933, as amended (the "1933 Act"), including the related base prospectus
relating to the Company Shares (the "Company Registration Statement") and (ii) a
shelf registration statement on Form S-3 (No. 333-108792) covering the
registration of the IR Shares under the 1933 Act, including the related base
prospectus relating to the IR Shares (the "IR Registration Statement"). Promptly
after execution and delivery of this Agreement, the Company will prepare and
file a prospectus in accordance with the provisions of Rule 430A ("Rule 430A")
of the rules and regulations of the Commission under the 1933 Act (the "1933 Act
Regulations") and paragraph (b) of Rule 424 ("Rule 424(b)") of the 1933 Act
Regulations relating to each of the Company Registration Statement and the IR
Registration Statement. The information included in such prospectus that was
omitted from either the Company Registration Statement or the IR Registration
Statement at the respective

                                         1



times they became effective but that is deemed to be part of either the Company
Registration Statement or the IR Registration Statement, as applicable, at the
respective times they became effective pursuant to paragraph (b) of Rule 430A is
referred to as "Rule 430A Information." The Company Registration Statement and
the IR Registration Statement, including the exhibits thereto, schedules
thereto, if any, and the documents incorporated or deemed incorporated by
reference therein pursuant to Item 12 of Form S-3 under the 1933 Act, at the
time they became effective, and including the Rule 430A Information, are herein
referred to collectively as the "Registration Statements." Any registration
statement filed pursuant to Rule 462(b) of the 1933 Act Regulations is herein
referred to as a "Rule 462(b) Registration Statement," and after such filing the
term "Registration Statements" shall be deemed to include any Rule 462(b)
Registration Statement. The final prospectus, including both the base prospectus
contained in the Company Registration Statement and the base prospectus
contained in the IR Registration Statement and any prospectus supplement
relating to the Securities included in the Registration Statements and the
documents incorporated or deemed incorporated by reference therein pursuant to
Item 12 of Form S-3 under the 1933 Act, in the form first furnished to the
Underwriter for use in connection with the offering of the Securities, is herein
called the "Prospectus." For purposes of this Agreement, all references to the
Registration Statements, the Prospectus or any amendment or supplement to any of
the foregoing shall be deemed to refer to and include the copy filed with the
Commission pursuant to its Electronic Data Gathering, Analysis and Retrieval
system ("EDGAR").

         Pursuant to a stock and asset purchase agreement dated as of October
16, 2002 (the "Acquisition Agreement") with Ingersoll-Rand Company Limited
("IR") on behalf of itself and other sellers party thereto (collectively, the
"Acquisition Parties"), on February 18, 2003 the Company acquired, directly or
indirectly, (i) all or a portion of the outstanding shares of capital stock, as
set forth in the Acquisition Agreement, of the companies listed on Schedule B of
the Acquisition Agreement (the "Acquisition Subsidiaries"), (ii) all or a
portion of the equity interests, as set forth in the Acquisition Agreement, of
the companies listed on Schedule C of the Acquisition Agreement (the "Venture
Entities") and (iii) those assets listed in Schedule E of the Acquisition
Agreement (the "Separate Assets"). The Acquisition Subsidiaries, the Venture
Entities and the Separate Assets are hereinafter referred to collectively as
"Torrington," and the purchase of Torrington by the Company pursuant to the
Acquisition Agreement is hereafter referred to as the "Torrington Acquisition."

         All references in this Agreement to financial statements and schedules
and other information which is "contained," "included" or "stated" in the
Registration Statements or the Prospectus (or other references of like import)
shall be deemed to mean and include all such financial statements and schedules
and other information which is or is deemed to be incorporated by reference in
the Registration Statements or the Prospectus, as the case may be; and all
references in this Agreement to amendments or supplements to the Registration
Statements or the Prospectus shall be deemed to mean and include the filing of
any document under the Securities Exchange Act of 1934 (the "1934 Act") which is
incorporated by reference in the Registration Statements or the Prospectus, as
the case may be.

                                       2



         SECTION 1. Representations and Warranties.

         (a)      Representations and Warranties by the Company. The Company
represents and warrants to the Underwriter as of the date hereof and as of the
Closing Time referred to in Section 2(c) hereof, and agrees with the
Underwriter, as follows:

                  (i)      Compliance with Registration Requirements. The
         Company meets the requirements for use of Form S-3 under the 1933 Act.
         Each of the Registration Statements and any Rule 462(b) Registration
         Statement has become effective under the 1933 Act and no stop order
         suspending the effectiveness of either of the Registration Statements
         or any Rule 462(b) Registration Statements is in effect under the 1933
         Act and no proceedings for that purpose have been instituted or are
         pending or, to the knowledge of the Company, are contemplated by the
         Commission, and any request on the part of the Commission for
         additional information has been complied with.

                  At the respective times the Registration Statements, any Rule
         462(b) Registration Statements and any post-effective amendments
         thereto became effective and at the Closing Time, the Registration
         Statements, the Rule 462(b) Registration Statements and any amendments
         and supplements thereto with respect to the Securities complied and
         will comply in all material respects with the requirements of the 1933
         Act and the 1933 Act Regulations and did not and will not contain any
         untrue statement of a material fact or omit to state a material fact
         required to be stated therein or necessary to make the statements
         therein not misleading. Neither the Prospectus nor any amendments or
         supplements thereto, at the time the Prospectus or any such amendment
         or supplement was issued and at the Closing Time, included or will
         include any untrue statement of a material fact or omitted or will omit
         to state a material fact necessary in order to make the statements
         therein, in the light of the circumstances under which they were made,
         not misleading. The representations and warranties in this subsection
         shall not apply to statements in or omissions from the Registration
         Statements or Prospectus made in reliance upon and in conformity with
         (i) information furnished to the Company in writing by the Underwriter
         expressly for use in the Registration Statements or Prospectus or (ii)
         information furnished to the Company in writing by the Selling
         Stockholder expressly for use in the IR Registration Statement or in
         the Prospectus.

                  The prospectuses filed as part of each of the Registration
         Statements as originally filed or as part of any amendment thereto, or
         filed pursuant to Rule 424 under the 1933 Act with respect to the
         Securities, complied when so filed in all material respects with the
         1933 Act Regulations and the Prospectus delivered to the Underwriter
         for use in connection with this offering was identical to the
         electronically transmitted copies thereof filed with the Commission
         pursuant to EDGAR, except to the extent permitted by Regulation S-T
         under the 1933 Act ("Regulation S-T").

                  (ii)     Incorporated Documents. The documents incorporated or
         deemed to be incorporated by reference in the Registration Statements
         and the Prospectus, at the respective times they were or hereafter are
         filed with the Commission, complied and will comply in all material
         respects with the requirements of the 1934 Act and the rules and
         regulations of the Commission thereunder (the "1934 Act Regulations"),
         as applicable,

                                       3



         and, when read together with the other information in the Prospectus,
         at the respective times the Registration Statements became effective,
         at the time the Prospectus was issued and at the Closing Time, did not
         and will not contain an untrue statement of a material fact or omit to
         state a material fact required to be stated therein or necessary to
         make the statements therein not misleading.

                  (iii)    Independent Accountants. (A) Ernst & Young LLP, the
         accountants who certified the financial statements and supporting
         schedules of the Company incorporated by reference in the Registration
         Statements, are independent public accountants with respect to the
         Company within the meaning of the 1933 Act and the 1933 Act
         Regulations; and (B) PricewaterhouseCoopers LLP, the accountants who
         certified the financial statements and supporting schedules of
         Torrington which were incorporated by reference in the Registration
         Statements and used in the preparation of the pro forma financial
         information set forth or incorporated by reference in the Registration
         Statements, are independent public accountants with respect to
         Torrington within the meaning of the 1933 Act and the 1933 Act
         Regulations.

                  (iv)     Financial Statements. The financial statements for
         each of the Company and Torrington incorporated by reference in the
         Registration Statements and the Prospectus, together with the related
         schedule and notes thereto, present fairly, in all material respects,
         the financial position of each of the Company and Torrington and their
         respective consolidated subsidiaries at the dates indicated and the
         statement of operations, stockholders' equity and cash flows of each of
         the Company and Torrington and their respective consolidated
         subsidiaries for the periods specified; said financial statements have
         been prepared in conformity with generally accepted accounting
         principles ("GAAP") applied on a consistent basis throughout the
         periods involved subject, in the case of the unaudited interim
         financial statements, to normal year-end adjustments that have not been
         made and are not expected to be material in amount. The supporting
         schedule incorporated by reference in the Registration Statements
         presents fairly, in all material respects, in accordance with GAAP the
         information required to be stated therein. The pro forma financial
         statements and the related notes thereto incorporated by reference in
         the Registration Statements and the Prospectus present fairly, in all
         material respects, the information shown therein, have been prepared in
         accordance with the Commission's rules and guidelines with respect to
         pro forma financial statements and have been properly compiled on the
         bases described therein, and the assumptions used in the preparation
         thereof are reasonable and the adjustments used therein are appropriate
         to give effect to the transactions and circumstances referred to
         therein.

                  (v)      No Material Adverse Change in Business. Since the
         respective dates as of which information is given in the Registration
         Statements and the Prospectus, except as otherwise stated therein, (A)
         there has been no material adverse change in the condition, financial
         or otherwise, or in the earnings, business affairs or business
         prospects of the Company and its subsidiaries taken as a whole, whether
         or not arising in the ordinary course of business, (B) there have been
         no transactions entered into by the Company or any of its subsidiaries,
         other than those in the ordinary course of business or in connection
         with the integration of Torrington, which are material with respect to
         the Company and its subsidiaries, taken as a whole, and (C) except for
         regular quarterly

                                       4



         dividends on the Common Stock in amounts per share that are consistent
         with past practice, there has been no dividend or distribution of any
         kind declared, paid or made by the Company on any class of its capital
         stock.

                  (vi)     Good Standing of the Company. The Company has been
         duly incorporated and is validly existing as a corporation in good
         standing under the laws of the State of Ohio and has corporate power
         and authority to own, lease and operate its properties and to conduct
         its business as described in the Prospectus and to enter into and
         perform its obligations under this Agreement; and the Company is duly
         qualified as a foreign corporation to transact business and is in good
         standing in each other jurisdiction in which such qualification is
         required, whether by reason of the ownership or leasing of property or
         the conduct of business, except where the failure so to qualify or to
         be in good standing would not result in a Material Adverse Effect. As
         used in this Agreement, the term "Material Adverse Effect" means any
         material adverse change in the condition, financial or otherwise, or in
         the earnings, business affairs or business prospects of the Company and
         its subsidiaries, taken as a whole, whether or not arising in the
         ordinary course of business.

                  (vii)    Good Standing of Subsidiaries. Each subsidiary of the
         Company that is material to the business, financial condition or
         results of operations of the Company, taken as a whole, (A) is set
         forth on Schedule B hereto (each a "Subsidiary" and, collectively, the
         "Subsidiaries"), (B) has been duly organized and is validly existing
         and, where applicable, is in good standing under the laws of the
         jurisdiction of its incorporation, formation or organization, as
         applicable, and has the requisite corporate or similar power, as the
         case may be, and authority to own, lease and operate its assets and
         properties and to conduct its business as it is now being conducted and
         as described in the Prospectus; and (C) is duly qualified or licensed
         to transact business and is, where applicable, in good standing in each
         other jurisdiction in which such qualification or license is required,
         whether by reason of the ownership or leasing of property or the
         conduct of business, except where the failure so to qualify or to be in
         good standing would not result in a Material Adverse Effect; except as
         otherwise disclosed in the Registration Statements, all of the issued
         and outstanding capital stock of each such Subsidiary has been duly
         authorized and validly issued, is fully paid and non-assessable and is
         owned by the Company, directly or through subsidiaries, free and clear
         of any security interest, mortgage, pledge, lien, encumbrance, claim or
         equity; and none of the outstanding shares of capital stock of any
         Subsidiary was issued in violation of the preemptive or similar rights
         of any securityholder of such Subsidiary. The only subsidiaries of the
         Company are (a) the Subsidiaries listed on Schedule B hereto and (b)
         certain other subsidiaries which, considered in the aggregate as a
         single subsidiary, are not material to the business, financial
         condition or results of operations of the Company, taken as a whole.

                  (viii)   Venture Entities. None of the Venture Entities is
         material to the business, financial condition or results of operations
         of the Company, taken as a whole.

                  (ix)     Authorization of Agreement. This Agreement has been
         duly authorized, executed and delivered by the Company.

                                       5



                  (x)      Authorization and Description of Securities. The
         Company Shares have been duly authorized for issuance and sale to the
         Underwriter pursuant to this Agreement and, when issued and delivered
         by the Company pursuant to this Agreement against payment of the
         consideration set forth herein, will be validly issued, fully paid and
         non-assessable; the Common Stock conforms to all statements relating
         thereto contained in the Prospectus and such description conforms to
         the rights set forth in the instruments defining the same; no holder of
         the Securities will be personally liable for any debts, obligations or
         liabilities of the Company by reason of being such a holder; and, the
         issuance and sale of the Company Shares by the Company is not subject
         to the preemptive or other similar rights of any securityholder of the
         Company.

                  (xi)     Absence of Defaults and Conflicts. Neither the
         Company nor its Subsidiaries is in violation of its charter or by-laws
         or similar charter document. Neither the Company nor its Subsidiaries
         is in default in the performance or observance of any obligation,
         agreement, covenant or condition contained in any contract, indenture,
         mortgage, deed of trust, loan or credit agreement, note, lease or other
         agreement or instrument to which the Company or its Subsidiaries is a
         party or by which it or any of them may be bound, or to which any of
         the property or assets of the Company or its Subsidiaries is subject
         (collectively, "Agreements and Instruments"), except for such defaults
         that would not result in a Material Adverse Effect. The execution,
         delivery and performance of this Agreement and the consummation of the
         transactions contemplated herein and in the Registration Statements,
         the issuance and sale of the Company Shares and the use of proceeds
         from the sale of the Company Shares as described in the Prospectus
         under the caption "Use of Proceeds", and compliance by the Company with
         its obligations hereunder have been duly authorized by all necessary
         corporate action and do not and will not, whether with or without the
         giving of notice or passage of time or both, conflict with or
         constitute a breach of, or default or Repayment Event (as defined
         below) under, or result in the creation or imposition of any lien,
         charge or encumbrance upon any of the respective property or assets of
         the Company or its subsidiaries pursuant to the Agreements and
         Instruments (except for such conflicts, breaches, Repayment Events or
         defaults or liens, charges or encumbrances that would not result in a
         Material Adverse Effect), nor will such action result in any violation
         of (A) the provisions of the charter or by-laws or similar charter
         document of the Company or its Subsidiaries or (B) any applicable law,
         statute, rule, regulation, judgment, order, writ or decree of any
         government, government instrumentality or court, domestic or foreign,
         having jurisdiction over the Company or its subsidiaries, or any of
         their respective assets, properties or operations (except with respect
         to clause (B) above, as would not result in a Material Adverse Effect).
         As used herein, a "Repayment Event" means any event or condition which
         gives the holder of any note, debenture or other evidence of
         indebtedness (or any person acting on such holder's behalf) the right
         to require the repurchase, redemption or repayment of all or a portion
         of such indebtedness by the Company or its subsidiaries, as the case
         may be.

                  (xii)    Distributions and Dividend Payments. Except as
         described in or contemplated by the Registration Statements and the
         Prospectus and except as prohibited by local law in circumstances that
         would not, individually or in the aggregate, result in a Material
         Adverse Effect, no Subsidiary of the Company is currently prohibited,
         directly

                                       6



         or indirectly, from paying any dividends to the Company, from making
         any other distribution on such Subsidiary's capital stock or other
         equity interests, as applicable, from repaying to the Company any loans
         or advances to such Subsidiary from the Company, or from transferring
         any of such Subsidiary's property or assets to the Company or any other
         Subsidiary of the Company.

                  (xiii)   Internal Controls. The Company maintains a system of
         internal accounting controls sufficient to provide reasonable assurance
         that (1) transactions are executed in accordance with management's
         general or specific authorizations; (2) transactions are recorded as
         necessary to permit preparation of financial statements in conformity
         with GAAP and to maintain asset accountability; (3) access to assets is
         permitted only in accordance with management's general or specific
         authorization; and (4) the recorded accountability for assets is
         compared with the existing assets at reasonable intervals and
         appropriate action is taken with respect to any differences.

                  (xiv)    Absence of Labor Dispute. No labor dispute with the
         employees of the Company or any of its subsidiaries exists or, to the
         knowledge of the Company, is imminent, and the Company is not aware of
         any existing or imminent labor disturbance by the employees of any of
         its or its subsidiaries' principal suppliers, manufacturers, customers
         or contractors, which, in either case, may reasonably be expected to
         result in a Material Adverse Effect.

                  (xv)     Absence of Proceedings. There are no legal or
         governmental proceedings pending or, to the Company's knowledge,
         threatened to which the Company or any of its Subsidiaries is subject,
         or to which any of the properties of the Company or any of its
         Subsidiaries is subject, that are required to be described in the
         Registration Statements or the Prospectus and are not so described or
         any statutes, regulations, contracts or other documents that are
         required to be described in the Registration Statements or the
         Prospectus or to be filed as an exhibit to the Registration Statements
         that are not described or filed as required.

                  (xvi)    Possession of Intellectual Property. Each of the
         Company and its Subsidiaries own or possess, or can acquire on
         reasonable terms, adequate patents, rights to use patents, licenses,
         inventions, copyrights, know-how (including trade secrets and other
         unpatented and/or unpatentable proprietary or confidential information,
         systems or procedures), trademarks, service marks, trade names or other
         intellectual property (collectively, "Intellectual Property") necessary
         to carry on the business now operated by them, except where the failure
         to own or possess such Intellectual Property would not result, singly
         or in the aggregate, in a Material Adverse Effect, and neither the
         Company nor its Subsidiaries has received any notice or has a
         reasonable basis to believe that the conduct of their respective
         businesses will result in any infringement of or conflict with asserted
         rights of others with respect to any Intellectual Property or of any
         facts or circumstances which would render any Intellectual Property
         invalid or inadequate to protect the interest of any of the Company and
         its subsidiaries therein, and which infringement or conflict (if the
         subject of any unfavorable decision, ruling or finding) or invalidity
         or inadequacy, singly or in the aggregate, would result in a Material
         Adverse Effect.

                                       7



                  (xvii)   Absence of Further Requirements. No filing with, or
         authorization, approval, consent, license, order, registration,
         qualification or decree of, any court or governmental authority or
         agency is necessary or required for the performance by the Company of
         its obligations hereunder, in connection with the offering, issuance or
         sale of the Securities hereunder or the consummation of the
         transactions contemplated by this Agreement and the Prospectus, except
         such as have already been obtained or as may be required under the 1933
         Act or the 1933 Act Regulations or state securities laws.

                  (xviii)  Possession of Licenses and Permits. Except as would
         not result, singly or in the aggregate, in a Material Adverse Effect,
         each of the Company and its Subsidiaries own or possess such permits,
         licenses, approvals, consents and other authorizations (collectively,
         "Governmental Licenses") issued by the appropriate federal, state,
         local or foreign regulatory agencies or bodies necessary to conduct
         their respective businesses as now operated; each of the Company and
         its Subsidiaries are in compliance with the terms and conditions of all
         such Governmental Licenses, except where the failure so to comply would
         not, singly or in the aggregate, have a Material Adverse Effect; all of
         the Governmental Licenses are valid and in full force and effect,
         except when the invalidity of such Governmental Licenses or the failure
         of such Governmental Licenses to be in full force and effect would not
         have a Material Adverse Effect; and neither the Company nor its
         Subsidiaries has received any notice of proceedings relating to the
         revocation or modification of any such Governmental Licenses which,
         singly or in the aggregate, if the subject of an unfavorable decision,
         ruling or finding, would result in a Material Adverse Effect.

                  (xix)    Title to Property. (A) Each of the Company and its
         subsidiaries have good and marketable title to all real property owned
         by them and good title to all other properties owned by them, in each
         case, free and clear of all mortgages, pledges, liens, security
         interests, claims, restrictions or encumbrances of any kind except such
         as (a) are described in the Prospectus or (b) do not, singly or in the
         aggregate, materially affect the value of such property and do not
         interfere with the use made of such property by the Company; and (B)
         except as would not result, singly or in the aggregate, in a Material
         Adverse Effect, all of the leases and subleases which are material to
         the business of the Company and its subsidiaries and under which any of
         them hold properties described in the Prospectus, are in full force and
         effect, and none of them has any notice of any material claim of any
         sort that has been asserted by anyone adverse to any of their rights
         under any of the leases or subleases mentioned above, or affecting or
         questioning any of their rights to the continued possession of the
         leased or subleased premises under any such lease or sublease.

                  (xx)     Investment Company Act. The Company is not, and upon
         the issuance and sale of the Company Shares as contemplated herein and
         the application of the net proceeds therefrom as described in the
         Prospectus will not be, an "investment company" or an entity
         "controlled" by an "investment company" as such terms are defined in
         the Investment Company Act of 1940, as amended (the "1940 Act").

                  (xxi)    Registration Rights. Except as disclosed in the
         Registration Statements, there are no persons with registration rights
         or other similar rights to have any securities

                                       8



         registered pursuant to the Registration Statements or otherwise
         registered by the Company under the 1933 Act.

                  (xxii)   Environmental Laws. Except as disclosed in the
         Registration Statements and except as would not, singly or in the
         aggregate, result in a Material Adverse Effect, (A) neither the Company
         nor its Subsidiaries is in violation of any federal, state, local or
         foreign statute, law, rule, regulation, ordinance, code, policy or any
         judicial or administrative interpretation thereof, relating to
         pollution or protection of human health, the environment (including,
         without limitation, ambient air, surface water, groundwater, land
         surface or subsurface strata) or wildlife, including, without
         limitation, laws and regulations relating to the release or threatened
         release of chemicals, pollutants, contaminants, wastes, toxic
         substances, hazardous substances, petroleum or petroleum products
         (collectively, "Hazardous Materials") or to the manufacture,
         processing, distribution, use, treatment, storage, disposal, transport
         or handling of Hazardous Materials (collectively, "Environmental
         Laws"), (B) each of the Company and its Subsidiaries have all permits,
         authorizations and approvals required under any applicable
         Environmental Laws and are each in compliance with their requirements,
         (C) there are no pending or, to the Company's knowledge, threatened
         administrative, regulatory or judicial actions, suits, demands, demand
         letters, claims, liens, notices of noncompliance or violation,
         investigation or proceedings relating to any Environmental Law against
         any of the Company or its Subsidiaries and (D) the Company is not aware
         of any events or circumstances that might reasonably be expected to
         form the basis of an order for clean-up or remediation, or an action,
         suit or proceeding by any private party or governmental body or agency,
         against or affecting any of the Company or its Subsidiaries relating to
         Hazardous Materials or any Environmental Laws.

         (b)      Representations and Warranties by the Selling Stockholder. The
Selling Stockholder represents and warrants to the Underwriter as of the date
hereof and as of the Closing Time, and agrees with the Underwriter, as follows:

                  (i)      Information Furnished by the Selling Stockholder.
         None of the "Selling Stockholder Information" (as defined in Section
         1(b)(ix) below) included at the time the IR Registration Statement
         became effective, or includes as of the date hereof, any untrue
         statement of a material fact or as of such effective date omitted, or
         as of the date hereof omits, to state a material fact necessary in
         order to make the statements therein, in the light of the circumstances
         under which they were made, not misleading.

                  (ii)     Authorization of Agreements. The Selling Stockholder
         has the full right, power and authority to enter into this Agreement
         and to sell, transfer and deliver the IR Shares. The execution and
         delivery of this Agreement and the sale and delivery of the IR Shares
         and compliance by the Selling Stockholder with its obligations
         hereunder have been duly authorized by the Selling Stockholder and do
         not and will not, whether with or without the giving of notice or
         passage of time or both, conflict with or constitute a breach of, or
         default under, or result in the creation or imposition of any lien,
         charge or encumbrance upon the IR Shares nor will such action result in
         any violation of the provisions of the charter or by-laws or other
         organizational instrument of the Selling Stockholder, if applicable, or
         any applicable treaty, law, statute, rule, regulation,

                                       9



         judgment, order, writ or decree of any government, government
         instrumentality or court, domestic or foreign, having jurisdiction over
         the Selling Stockholder or any of its properties.

                  (iii)    Good and Marketable Title. The Selling Stockholder,
         together with its parents, including Ingersoll-Rand Company Limited, is
         the record and beneficial owner of the IR Shares and has and will at
         the Closing Time have good and unencumbered title to the IR Shares
         hereunder, free and clear of any security interest, mortgage, pledge,
         lien, charge, claim, equity or encumbrance of any kind, other than
         pursuant to this Agreement; and upon delivery of the IR Shares and
         payment of the purchase price therefor as herein contemplated, assuming
         the Underwriter has no notice of any adverse claim, (within the meaning
         of Section 8-105 of the New York Uniform Commercial Code ("NYUCC")) at
         the time such IR Shares are credited to the Underwriter's account or
         accounts maintained with The Depository Trust Company ("DTC") or other
         securities intermediary (each, a "Securities Account"), the
         Underwriter, by making payment therefore as provided herein will have
         acquired a security entitlement (within the meaning of Section
         8-102(a)(17) of the NYUCC) to such IR Shares, and no action based on an
         adverse claim (within the meaning of Section 8-105 of the NYUCC)
         whether framed in conversion, replevin, constructive trust, equitable
         lien or other theory, may be asserted against the Underwriter with
         respect to such IR Shares.

                  (iv)     Absence of Manipulation. The Selling Stockholder has
         not taken, and will not take, directly or indirectly, any action which
         is designed to or which has constituted or which might reasonably be
         expected to cause or result, under the 1934 Act or otherwise, in
         stabilization or manipulation of the price of any security of the
         Company to facilitate the sale or resale of the IR Shares.

                  (v)      Absence of Further Requirements. No filing with, or
         consent, approval, authorization, order, registration, qualification or
         decree of, any court or governmental authority or agency, domestic or
         foreign, is necessary or required for the performance by the Selling
         Stockholder of its obligations hereunder or in connection with the sale
         and delivery of the IR Shares hereunder, except such as may have
         previously been made or obtained or as may be required under the 1933
         Act or the 1933 Act Regulations or state securities laws.

                  (vi)     Restriction on Sale of Securities. During a period of
         90 days from the date of the Prospectus, the Selling Stockholder will
         not, without the prior written consent of the Underwriter, (i) directly
         or indirectly offer, pledge, sell, contract to sell, sell any option or
         contract to purchase, purchase any option or contract to sell, grant
         any option, right or warrant to purchase or otherwise transfer or
         dispose of, directly or indirectly, any share of Common Stock or any
         securities convertible into or exercisable or exchangeable for Common
         Stock or cause or participate in the filing of any registration
         statement under the 1933 Act with respect to any of the foregoing or
         (ii) enter into any swap or any other agreement or any transaction that
         transfers, in whole or in part, directly or indirectly, the economic
         consequence of ownership of the Common Stock, whether any such swap or
         transaction described in clause (i) or (ii) above is to be settled by
         delivery of Common

                                       10



         Stock or such other securities, in cash or otherwise. The foregoing
         sentence shall not apply to the Securities to be sold hereunder.

                  (vii)    IR Shares Suitable for Transfer. At the Closing Time,
         the IR Shares shall be in suitable form for transfer to the Underwriter
         pursuant to The Depository Trust Company's FAST closing program and
         free from any restrictions on transfer.

                  (viii)   No Association with NASD. Neither the Selling
         Stockholder nor any of its affiliates directly, or indirectly through
         one or more intermediaries, controls, or is controlled by, or is under
         common control with, or has any other association with (within the
         meaning of Article I, Section 1(m) of the By-laws of the National
         Association of Securities Dealers, Inc.), any member firm of the
         National Association of Securities Dealers, Inc.

                  (ix)     Selling Stockholder Information. The Selling
         Stockholder agrees that it furnished to the Company the following
         written information expressly for use in the Prospectus and the IR
         Registration Statement: the information under the heading "Selling
         Stockholder" in the prospectus supplement contained in the Prospectus;
         and the last sentence in the first paragraph, the first sentence in the
         second paragraph and the fifth paragraph under the heading "Selling
         Stockholders" in the base prospectus contained in the IR Registration
         Statement (collectively, the "Selling Stockholder Information").

         (c)      Officer's Certificates. Any certificate signed by any officer
of the Company delivered to the Underwriter or to counsel for the Underwriter in
connection with the offering of the Securities contemplated hereby shall be
deemed a representation and warranty by the Company made as of the date of such
certificate (except to the extent a date is specified in such representation or
warranty, in which case such representation or warranty shall be deemed made as
of such date) to the Underwriter as to the matters covered thereby, and any
certificate signed by any officer of the Selling Stockholder delivered to the
Underwriter or to counsel for the Underwriter in connection with the offering of
the Securities contemplated hereby shall be deemed a representation and warranty
by the Selling Stockholder made as of the date of such certificate (except to
the extent a date is specified in such representation or warranty, in which case
such representation or warranty shall be deemed made as of such date) to the
Underwriter as to the matters covered thereby.

         SECTION 2. Sale and Delivery to Underwriter; Closing.

         (a)      The Securities. On the basis of the representations and
warranties herein contained and subject to the terms and conditions herein set
forth, (i) the Company agrees to sell to the Underwriter, and the Underwriter
agrees to purchase from the Company, the Company Shares and (ii) the Selling
Stockholder agrees to sell to the Underwriter, and the Underwriter agrees to
purchase from the Selling Stockholder, the IR Shares, in each case, at the price
set forth in Schedule A hereto.

         (b)      Payment. Payment of the purchase price for, and delivery of,
the Securities shall be made at the offices of Jones Day, located at 222 East
41st Street, New York, New York, or at such other place as shall be agreed upon
by the Underwriter, the Company and the Selling

                                       11


Stockholder, at 10:00 A.M. (Eastern time) on the third business day after the
date hereof, or such other time not later than ten business days after such date
as shall be agreed upon by the Underwriter, the Company and the Selling
Stockholder (such time and date of payment and delivery being herein called
"Closing Time").

         Payment for the Company Shares shall be made to the Company by wire
transfer of immediately available funds to a bank account of the Company
designated by the Company, against delivery of the Company Shares for the
account of the Underwriter. Payment for the IR Shares shall be made to the
Selling Stockholder by wire transfer of immediately available funds to a bank
account of the Selling Stockholder designated by the Selling Stockholder,
against delivery of the IR Shares for the account of the Underwriter.

         (c)      Denominations; Registration. Certificates for the Securities
shall be in such denominations and registered in such names as the Underwriter
may request in writing at least one full business day before the Closing Time.
The certificates for the Securities will be made available for examination and
packaging by the Underwriter in The City of New York not later than 10:00 A.M.
(Eastern time) on the business day prior to the Closing Time.

         Section 3. Covenants of the Company. The Company covenants with the
Underwriter as follows:

                  (a) Compliance with Securities Regulations and Commission
         Requests. The Company, subject to Section 3(b), will comply with the
         requirements of Rule 430A and will notify the Underwriter promptly, and
         confirm the notice in writing, (i) when any post-effective amendment to
         either of the Registration Statements shall become effective, or any
         supplement to the Prospectus or any amended Prospectus shall have been
         filed, (ii) of the receipt of any comments from the Commission, (iii)
         of any request by the Commission for any amendment to either of the
         Registration Statements or any amendment or supplement to the
         Prospectus or for additional information relating thereto, and (iv) of
         the issuance by the Commission of any stop order suspending the
         effectiveness of either of the Registration Statements or of the
         suspension of the qualification of the Securities for offering or sale
         in any jurisdiction or of the initiation or threatening of any
         proceedings for any of such purposes. The Company will promptly effect
         the filings necessary pursuant to Rule 424(b) and will take such steps
         as it deems necessary to ascertain promptly whether the form of
         prospectus transmitted for filing under Rule 424(b) was received for
         filing by the Commission and, in the event that it was not, it will
         promptly file such prospectus. The Company will make every reasonable
         effort to prevent the issuance of any stop order and, if any stop order
         is issued, to obtain the lifting thereof as soon as possible.

                  (b) Filing of Amendments. Until the completion of the
         distribution of the Securities, the Company will give the Underwriter
         notice of its intention to file or prepare any amendment to either of
         the Registration Statements (including any filing under Rule 462(b)),
         or any amendment, supplement or revision to either the base prospectus
         included in either of the Registration Statements at the respective
         times they became effective or to the Prospectus, whether pursuant to
         the 1933 Act, the 1934 Act or otherwise, will furnish the Underwriter
         with copies of any such documents a reasonable

                                       12


         amount of time prior to such proposed filing or use, as the case may
         be, and will not file or use any such document to which the Underwriter
         or counsel for the Underwriter shall reasonably object.

                  (c) Delivery of Registration Statements. The Company has
         furnished or will deliver to the Underwriter and counsel for the
         Underwriter, without charge, signed copies of the Registration
         Statements as originally filed and of each amendment thereto (including
         exhibits filed therewith or incorporated by reference therein and
         documents incorporated or deemed to be incorporated by reference
         therein) and will also deliver to the Underwriter, without charge, a
         conformed copy of the IR Registration Statement as originally filed and
         of each amendment thereto (without exhibits). Such copies of the IR
         Registration Statement and each amendment thereto furnished to the
         Underwriter will be identical to the electronically transmitted copies
         thereof filed with the Commission pursuant to EDGAR, except to the
         extent permitted by Regulation S-T.

                  (d) Delivery of Prospectuses. The Company will furnish to the
         Underwriter, without charge, during the period when the Prospectus is
         required to be delivered under the 1933 Act or the 1934 Act, such
         number of copies of the Prospectus (as amended or supplemented) as the
         Underwriter may reasonably request. The Prospectus and any amendments
         or supplements thereto furnished to the Underwriter will be identical
         to the electronically transmitted copies thereof filed with the
         Commission pursuant to EDGAR, except to the extent permitted by
         Regulation S-T.

                  (e) Continued Compliance with Securities Laws. The Company
         will comply with the 1933 Act and the 1933 Act Regulations and the 1934
         Act and the 1934 Act Regulations so as to permit the completion of the
         distribution of the Securities as contemplated in this Agreement and in
         the Prospectus. If at any time when a prospectus is required by the
         1933 Act to be delivered in connection with sales of the Securities,
         any event shall occur or condition shall exist as a result of which it
         is necessary, in the opinion of counsel for the Underwriter or in the
         judgment of the Company, to amend either of the Registration Statements
         or amend or supplement the Prospectus in order that the Prospectus will
         not include any untrue statements of a material fact or omit to state a
         material fact necessary in order to make the statements therein not
         misleading in the light of the circumstances existing at the time it is
         delivered to a purchaser, or if it shall be necessary, in the opinion
         of such counsel, at any such time to amend either of the Registration
         Statements or amend or supplement the Prospectus in order to comply
         with the requirements of the 1933 Act or the 1933 Act Regulations, the
         Company will promptly prepare and file with the Commission, subject to
         Section 3(b), such amendment or supplement as may be necessary to
         correct such statement or omission or to make the Registration
         Statements or the Prospectus comply with such requirements, and the
         Company will furnish to the Underwriter such number of copies of such
         amendment or supplement as the Underwriter may reasonably request.

                  (f) Blue Sky Qualifications. The Company will use its
         reasonable best efforts, in cooperation with the Underwriter, to
         qualify the Securities for offering and sale under the applicable
         securities laws of such states and other jurisdictions (domestic or
         foreign) as the Underwriter may reasonably designate and to maintain
         such qualifications in effect

                                       13


         for a period of not less than one year from the later of the effective
         date of the IR Registration Statement and any Rule 462(b) Registration
         Statement; provided, however, that the Company shall not be obligated
         to file any general consent to service of process or to qualify as a
         foreign corporation or as a dealer in securities in any jurisdiction in
         which it is not so qualified or to subject itself to taxation in
         respect of doing business in any jurisdiction in which it is not
         otherwise so subject. In each jurisdiction in which the Securities have
         been so qualified, the Company will file such statements and reports as
         may be required by the laws of such jurisdiction to continue such
         qualification in effect for a period of not less than one year from the
         effective date of the IR Registration Statement and any Rule 462(b)
         Registration Statement.

                  (g) Rule 158. The Company will timely file such reports
         pursuant to the 1934 Act as are necessary in order to make generally
         available to its securityholders within the required time periods an
         earnings statement covering a period of at least twelve months,
         beginning with the first fiscal quarter of the Company after the
         effective date of the IR Registration Statement (as the term "effective
         date" is defined in Rule 158(c) under the 1933 Act), which earnings
         statement shall satisfy the provisions of Section 11(a) of the 1933
         Act.

                  (h) Use of Proceeds. The Company will use the net proceeds
         received by it from the sale of the Company Shares in the manner
         specified in the Prospectus under the caption "Use of Proceeds."

                  (i) Listing. The Company will use its best efforts to effect
         and maintain the listing of the Securities on The New York Stock
         Exchange and will file with the New York Stock Exchange all documents
         and notices required by the New York Stock Exchange of companies that
         have securities listed on the New York Stock Exchange.

                  (j) Restriction on Sale of Securities. During a period of 90
         days from the date of the Prospectus, the Company will not, without the
         prior written consent of the Underwriter, (i) directly or indirectly,
         offer, pledge, sell, contract to sell, sell any option or contract to
         purchase, purchase any option or contract to sell, grant any option,
         right or warrant to purchase or otherwise transfer or dispose of any
         share of Common Stock or any securities convertible into or exercisable
         or exchangeable for Common Stock or file any registration statement
         under the 1933 Act with respect to any of the foregoing or (ii) enter
         into any swap or any other agreement or any transaction that transfers,
         in whole or in part, directly or indirectly, the economic consequence
         of ownership of the Common Stock, whether any such swap or transaction
         described in clause (i) or (ii) above is to be settled by delivery of
         Common Stock or such other securities, in cash or otherwise. The
         foregoing sentence shall not apply to (A) the Securities to be sold
         hereunder, (B) any shares of Common Stock issued by the Company upon
         the exercise of an option outstanding on the date hereof, (C) any
         shares of Common Stock issued or options to purchase Common Stock
         granted in the ordinary course of business pursuant to existing
         employee or director compensation plans of the Company (and with
         respect to sales of any shares of Common Stock issued pursuant to any
         such plan, the Company shall be permitted to file a Registration
         Statement on Form S-8 under the 1933 Act), or (D) any

                                       14


         shares of Common Stock issued in the ordinary course of business
         pursuant to any existing dividend reinvestment plan of the Company.

                  (k) Reporting Requirements. The Company, during the period
         when the Prospectus is required to be delivered under the 1933 Act or
         the 1934 Act, will file all documents required to be filed with the
         Commission pursuant to the 1934 Act within the time periods required by
         the 1934 Act and the 1934 Act Regulations.

         Section 4. Payment of Expenses.

         (a)      Expenses of the Company. The Company will pay all expenses
incident to the performance of its obligations under this Agreement, including
(i) the preparation, printing and filing of the Registration Statements
(including financial statements and exhibits) as originally filed and of each
amendment thereto, (ii) the reproduction and delivery to the Underwriter of this
Agreement, and such other documents as may be required in connection with the
offering, purchase, sale, issuance or delivery of the Company Shares, (iii) the
preparation, issuance and delivery of the certificates for the Company Shares,
including any stock or other transfer taxes and any stamp or other duties
payable upon the sale, issuance or delivery of the Company Shares, to the
Underwriter, (iv) the fees and disbursements of the Company's counsel,
accountants and other advisors, (v) the qualification of the Securities under
securities laws in accordance with the provisions of Section 3(f) hereof,
including filing fees and the reasonable fees and disbursements of counsel for
the Underwriter in connection therewith and in connection with the preparation
of the Blue Sky Survey and any supplement thereto, (vi) the printing and
delivery to the Underwriter of copies of the Prospectus and any amendments or
supplements thereto, (vii) the reproduction and delivery to the Underwriter of
copies of the Blue Sky Survey and any supplement thereto, (viii) the fees and
expenses of any transfer agent or registrar for the Securities and (ix) the fees
and expenses incurred in connection with the listing of the Securities on the
New York Stock Exchange.

         (b)      Expenses of the Selling Stockholder. The Selling Stockholder
will pay all expenses incident to the performance of its obligations under this
Agreement, including (i) the preparation, and delivery of the certificates for
the IR Shares, including any stock or other transfer taxes and any stamp duties,
capital duties or other duties payable upon the sale and delivery of the IR
Shares to the Underwriter and (ii) the fees and disbursements of its counsel and
accountants. Notwithstanding the foregoing, in the event of any conflict between
this Section 4(b) and the provisions of the Registration Rights Agreement dated
February 18, 2003 between the Company and the Selling Stockholder (the
"Registration Rights Agreement"), the provisions of the Registration Rights
Agreement shall control.

         (c)      Termination of Agreement. (i) If this Agreement is terminated
by the Underwriter in accordance with the provisions of Section 5 hereof because
of the failure of the Selling Stockholder to perform its obligations under
Sections 5(d), 5(e) or 5(h), or to furnish any items required to be provided by
it pursuant to Section 5(l), or because of any error or omission or failure on
the part of the Selling Stockholder with respect to any other provision of
Section 5 that results in the failure of a condition set forth in Section 5 to
be satisfied, the Selling Stockholder shall reimburse the Underwriter for all of
its reasonable out-of-pocket expenses, including the reasonable fees and
disbursements of counsel for the Underwriter. (ii) If this

                                       15


Agreement is terminated by the Underwriter in accordance with the provisions of
Section 5 hereof because of the failure of the Company to perform any of its
obligations (which obligations do not include the obligations of the Selling
Shareholder set forth in 4(c)(i) above) under Section 5 or Section 9(a)(i)
hereof, the Company shall reimburse the Underwriter for all of its reasonable
out-of-pocket expenses, including the reasonable fees and disbursements of
counsel for the Underwriter.

         Section 5. Conditions of Underwriter's Obligations. The obligations of
the Underwriter hereunder are subject to the accuracy of the representations and
warranties of the Company and the Selling Stockholder contained in Section 1
hereof or in certificates of any officer of the Company and the Selling
Stockholder delivered pursuant to the provisions hereof, to the performance by
the Company and the Selling Stockholder of each of their respective covenants
and other obligations hereunder, and to the following further conditions:

                  (a) Effectiveness of Registration Statements. Each of the
         Registration Statements, including any Rule 462(b) Registration
         Statement, has become effective and at Closing Time no stop order
         suspending the effectiveness of either of the Registration Statements
         shall have been issued under the 1933 Act or proceedings therefor
         initiated or, to the Company's knowledge, threatened by the Commission,
         and any request on the part of the Commission for additional
         information shall have been complied with to the reasonable
         satisfaction of counsel to the Underwriter. A prospectus containing the
         Rule 430A Information shall have been filed with the Commission in
         accordance with Rule 424(b) (or a post-effective amendment providing
         such information shall have been filed and declared effective in
         accordance with the requirements of Rule 430A).

                  (b) Opinion of Counsel for Company. At Closing Time, the
         Underwriter shall have received (A) the favorable opinion and (B) a
         letter, each dated as of Closing Time, of Jones Day, special counsel
         for the Company, in the form set forth in Exhibit A and Exhibit B,
         respectively.

                  (c) Opinion of the General Counsel of the Company. At Closing
         Time, the Underwriter shall have received the favorable opinion of
         William R. Burkhart, Senior Vice President and General Counsel of
         Company, in form and substance satisfactory to the Underwriter,
         substantially to the effect set forth in Exhibit C.

                  (d) Opinion of Counsel for the Selling Stockholder. At Closing
         Time, the Underwriter shall have received the favorable opinion, dated
         as of Closing Time, of Simpson Thacher & Bartlett LLP, counsel for the
         Selling Stockholder, in the form set forth in Exhibit D.

                  (e) Opinion of the General Counsel of the Selling Stockholder.
         At the Closing Time, the Underwriter shall have received the favorable
         opinion, dated as of Closing Time, of Patricia Nachtigal, the General
         Counsel of the Selling Stockholder, in form and substance satisfactory
         to the Underwriter, substantially to the effect set forth in Exhibit E.

                  (f) Opinion of Counsel for Underwriter. At Closing Time, the
         Underwriter shall have received the favorable opinion, dated as of
         Closing Time, of Shearman & Sterling

                                       16


         LLP, counsel for the Underwriter, in form and substance reasonably
         satisfactory to the Underwriter. In giving such opinion such counsel
         may rely, as to all matters governed by the laws of jurisdictions other
         than the law of the State of New York, and the federal law of the
         United States, upon the opinions of counsel satisfactory to the
         Underwriter. Such counsel may also state that, insofar as such opinion
         involves factual matters, they have relied, to the extent they deem
         proper, upon certificates of officers of the Company and its
         Subsidiaries, certificates of officers of the Selling Stockholder and
         certificates of public officials.

                  (g) Officers' Certificate. At Closing Time, there shall not
         have been, since the date hereof or since the respective dates as of
         which information is given in the Prospectus, any material adverse
         change in the condition, financial or otherwise, or in the earnings,
         business affairs or business prospects of the Company and its
         subsidiaries, taken as whole, whether or not arising in the ordinary
         course of business, which, individually or in the aggregate with all
         other of such changes, is materially adverse to the Company and its
         subsidiaries, taken as a whole; and the Underwriter shall have received
         a certificate of the President or a Vice President of the Company and
         of the chief financial or chief accounting officer of the Company,
         dated as of Closing Time, to the effect that, to such officer's
         knowledge, (i) there has been no such material adverse change referred
         to above, (ii) the representations and warranties in Section 1(a)
         hereof are true and correct with the same force and effect as though
         expressly made at and as of Closing Time and (iii) the Company has
         complied with all agreements and satisfied all conditions on its part
         to be performed or satisfied at or prior to Closing Time.

                  (h) Certificate of Selling Stockholder. At Closing Time, the
         Underwriter shall have received a certificate of the Senior Vice
         President and Chief Financial Officer of the Selling Stockholder, dated
         as of Closing Time, to the effect that (i) the representations and
         warranties of the Selling Stockholder contained in Section 1(b) hereof
         are true and correct in all respects with the same force and effect as
         though expressly made at and as of Closing Time and (ii) the Selling
         Stockholder has complied with all agreements and satisfied all
         conditions on its part to be performed under this Agreement at or prior
         to Closing Time.

                  (i) Comfort Letters of Accountants. (A) At the date hereof,
         the Underwriter shall have received from each of Ernst & Young LLP and
         PricewaterhouseCoopers LLP a letter dated the date hereof, in form and
         substance satisfactory to the Underwriter containing statements and
         information of the type ordinarily included in accountants' "comfort
         letters" to underwriters with respect to the financial statements and
         certain financial information contained in the Registration Statements
         and the Prospectus. (B) At Closing Time, the Underwriter shall have
         received from Ernst & Young LLP a letter dated as of the Closing Date
         to the effect that they reaffirm the statements made in the letter
         furnished by them pursuant to subsection (A) of this Section 5(i),
         except that the procedures performed by Ernst & Young LLP in connection
         with the letter shall have been completed not more than three business
         days prior to Closing Time.

                                       17


                  (j) Approval of Listing. At Closing Time, the Securities shall
         have been approved for listing on The New York Stock Exchange subject
         only to official notice of issuance with respect to the Company Shares.

                  (k) Lock-up Agreements. As of the date of this Agreement, the
         Company shall have used its best efforts to provide the Underwriter an
         agreement substantially in the form of Exhibit F hereto signed by the
         persons listed on Schedule C hereto. At the Closing Time, the
         Underwriter shall have received any of such agreements not provided at
         the date of this Agreement in accordance with the preceding sentence.

                  (l) Additional Documents. At Closing Time, counsel for the
         Underwriter shall have been furnished with such documents and opinions
         as they may reasonably require for the purpose of enabling them to pass
         upon the issuance and sale of the Securities as herein contemplated, or
         in order to evidence the accuracy of any of the representations or
         warranties, or the fulfillment of any of the conditions, herein
         contained; and all proceedings taken by the Company and the Selling
         Stockholder in connection with the issue and sale of the Company Shares
         and the sale of the IR Shares as herein contemplated shall be
         satisfactory in form and substance to the Underwriter and counsel for
         the Underwriter.

                  (m) Termination of Agreement. If any condition specified in
         this Section shall not have been fulfilled when and as required to be
         fulfilled, this Agreement the obligations of the Underwriter to
         purchase the Securities, may be terminated by the Underwriter by notice
         to the Company and to the Selling Stockholder at any time at or prior
         to Closing Time and such termination shall be without liability of any
         party to any other party except as provided in Section 4 and except
         that Sections 1, 6, 7 and 8 shall survive any such termination and
         remain in full force and effect.

                  (n) Registration Rights Agreement. For the avoidance of doubt,
         the Selling Stockholder shall have agreed (which agreement shall be
         evidenced by the Selling Stockholder's execution of this Agreement)
         that the offering and sale of the Company Shares pursuant to this
         Agreement shall be deemed to be a public sale or distribution as part
         of the IR Registration Statement consistent with the exception set
         forth in the parenthetical in clause (i) of Section 4(b) of the
         Registration Rights Agreement.

         Section 6. Indemnification.

         (a)      Indemnification of the Underwriter and the Selling Stockholder
by the Company. The Company agrees to indemnify and hold harmless each of the
Underwriter and the Selling Stockholder and each person, if any, who controls
the Underwriter or the Selling Stockholder within the meaning of Section 15 of
the 1933 Act or Section 20 of the 1934 Act as follows:

                  (i)      against any and all loss, liability, claim, damage
         and expense whatsoever, as incurred, to which the Underwriter or the
         Selling Stockholder or any such control person may become subject
         arising out of any untrue statement or alleged untrue statement of a
         material fact contained in either of the Registration Statements (or
         any amendment thereto), including the Rule 430A Information, if
         applicable, or the omission

                                       18


         or alleged omission therefrom of a material fact required to be stated
         therein or necessary to make the statements therein not misleading or
         arising out of any untrue statement or alleged untrue statement of a
         material fact included in the Prospectus (or any amendment or
         supplement thereto), or the omission or alleged omission therefrom of a
         material fact necessary in order to make the statements therein, in the
         light of the circumstances under which they were made, not misleading;

                  (ii)     against any and all loss, liability, claim, damage
         and expense whatsoever, as incurred, to the extent of the aggregate
         amount paid in settlement of any litigation, or any investigation or
         proceeding by any governmental agency or body, commenced or threatened,
         or of any claim whatsoever based upon any such untrue statement or
         omission, or any such alleged untrue statement or omission; provided
         that (subject to Section 6(d) below) any such settlement is effected
         with the written consent of the Company; and

                  (iii)    against any and all expense whatsoever, as incurred
         (including the fees and disbursements of counsel chosen by the
         Underwriter), reasonably incurred in investigating, preparing or
         defending against any litigation, or any investigation or proceeding by
         any governmental agency or body, commenced or threatened, or any claim
         whatsoever based upon any such untrue statement or omission, or any
         such alleged untrue statement or omission, to the extent that any such
         expense is not paid under (i) or (ii) above;

provided, however, that this indemnity agreement shall not apply to (1) any
loss, liability, claim, damage or expense to the extent arising out of any
untrue statement or omission or alleged untrue statement or omission made in
reliance upon and in conformity with written information furnished to the
Company by the Underwriter expressly for use in the Registration Statements (or
any amendment thereto), including the Rule 430A Information or the Prospectus
(or any amendment or supplement thereto), or (2) any loss, liability, claim,
damage or expense to the extent arising out of any untrue statement or omission
or alleged untrue statement or omission made in reliance upon and in conformity
with written information furnished to the Company by the Selling Stockholder
expressly for use in the IR Registration Statement (or any amendment thereto),
including the Rule 430A Information, or the prospectus supplement relating to
the Securities or the base prospectus contained in the IR Registration Statement
(or any amendment or supplement thereto); and provided further that the
indemnity agreement, with respect to the Underwriter and its related control
persons, contained in this Section 6(a) shall not apply to any loss, liability,
claim, damage or expense resulting from the fact that a court of competent
jurisdiction shall have made a determination that the untrue statement or
omission shall have been corrected in the Prospectus and a copy of the
Prospectus was delivered to the Underwriter in accordance with the terms hereof
and was not sent or given to such person by the Underwriter as required and
within the time required by the 1933 Act.

         Insofar as this indemnity agreement may permit indemnification for
liabilities under the 1933 Act of any person who is a partner of the Underwriter
or the Selling Stockholder or who controls the Underwriter or the Selling
Stockholder within the meaning of Section 15 of the 1933 Act or Section 20 of
the 1934 Act and who, at the date of this Agreement, is a director or officer of
the Company or controls the Company within the meaning of Section 15 of the 1933
Act or

                                       19


Section 20 of the 1934 Act, such indemnity agreement is subject to the
undertaking of the Company in the Registration Statements under Item 17.

         (b)      Indemnification of the Company, the Selling Stockholder,
Directors and Officers by the Underwriter. The Underwriter agrees to indemnify
and hold harmless each of the Company and the Selling Stockholder, their
respective directors, each of the Company's officers who signed the Registration
Statements, and each person, if any, who controls the Company or the Selling
Stockholder within the meaning of Section 15 of the 1933 Act or Section 20 of
the 1934 Act against any and all loss, liability, claim, damage and expense
whatsoever to which the Company or the Selling Stockholder may become subject as
described in the indemnity contained in subsection (a) of this Section, as
incurred, but only with respect to untrue statements or omissions, or alleged
untrue statements or omissions, made in either of the Registration Statements
(or any amendment thereto), including the Rule 430A Information or the
Prospectus (or any amendment or supplement thereto), but only to the extent made
in reliance upon and in conformity with written information furnished to the
Company by the Underwriter expressly for use in either of the Registration
Statements (or any amendment thereto) or the Prospectus (or any amendment or
supplement thereto).

         (c)      Indemnification of the Company, the Underwriter, Directors and
Officers by the Selling Stockholder. The Selling Stockholder agrees to indemnify
and hold harmless the Company and the Underwriter, their respective directors,
each of the Company's officers who signed the IR Registration Statement, and
each person, if any, who controls the Company or the Underwriter within the
meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act against any
and all loss, liability, claim, damage and expense whatsoever to which such
person may become subject as described in the indemnity contained in subsection
(a) of this Section, as incurred, but only with respect to untrue statements or
omissions, or alleged untrue statements or omissions, made in the IR
Registration Statement (or any amendment thereto), including the Rule 430A
Information or the prospectus supplement relating to the Securities or the base
prospectus contained in the IR Registration Statement (or any amendment or
supplement thereto), made in reliance upon and in conformity with written
information furnished to the Company by the Selling Stockholder expressly for
use in the IR Registration Statement (or any amendment thereto) or the
prospectus supplement relating to the Securities or the base prospectus
contained in the IR Registration Statement (or any amendment or supplement
thereto); provided, however, that the Selling Stockholder shall not be liable
for any amounts exceeding the product of the purchase price per share of the
Securities (not including discounts or commissions but before expenses), as set
forth in Schedule A hereto, and the number of IR Shares.

         (d)      Actions Against Parties; Notification. Each indemnified party
shall give notice as promptly as reasonably practicable to each indemnifying
party of any actiand inon commenced against it in respect of which indemnity may
be sought hereunder, but failure to so notify an indemnifying party shall not
relieve such indemnifying party from any liability hereunder unless and only to
the extent it did not otherwise learn of such action and it is not materially
prejudiced as a result thereof and in any event shall not relieve it from any
liability which it may have otherwise than on account of this indemnity
agreement. In the case of parties indemnified pursuant to Section 6(a) or
Section 6(c) above, counsel to the indemnified parties shall be selected by the
Underwriter and, if the Company is an indemnified party, the Company, and in

                                       20


the case of parties indemnified pursuant to Section 6(b) above, counsel to the
indemnified parties shall be selected by the Company. An indemnifying party may
participate at its own expense in the defense of any such action; provided,
however, that counsel to the indemnifying party shall not (except with the
consent of the indemnified party) also be counsel to the indemnified party. In
no event shall the indemnifying parties be liable for fees and expenses of more
than one counsel (in addition to any local counsel) separate from their own
counsel for all indemnified parties in connection with any one action or
separate but similar or related actions in the same jurisdiction arising out of
the same general allegations or circumstances. No indemnifying party shall,
without the prior written consent of the indemnified parties, settle or
compromise or consent to the entry of any judgment with respect to any
litigation, or any investigation or proceeding by any governmental agency or
body, commenced or threatened, or any claim whatsoever in respect of which
indemnification or contribution could be sought under this Section 6 or Section
7 hereof (whether or not the indemnified parties are actual or potential parties
thereto), unless such settlement, compromise or consent (i) includes an
unconditional release of each indemnified party from all liability arising out
of such litigation, investigation, proceeding or claim and (ii) does not include
a statement as to or an admission of fault, culpability or a failure to act by
or on behalf of any indemnified party.

         (e)      Settlement Without Consent if Failure to Reimburse. If at any
time an indemnified party shall have requested an indemnifying party to
reimburse the indemnified party for fees and expenses of counsel, such
indemnifying party agrees that it shall be liable for any settlement of the
nature contemplated by Section 6(a)(ii) effected without its written consent if
(i) such settlement is entered into more than 45 days after receipt by such
indemnifying party of the aforesaid request, (ii) such indemnifying party shall
have received notice of the terms of such settlement at least 30 days prior to
such settlement being entered into, and (iii) such indemnifying party shall not
have reimbursed such indemnified party in accordance with such request prior to
the date of such settlement; provided that an indemnifying party shall not be
liable for any such settlement effected without its consent if such indemnifying
party, prior to the date of such settlement, (1) reimburses such indemnified
party in accordance with such request for the amount of such fees and expenses
of counsel as the indemnifying party believes in good faith to be reasonable,
and (2) provides written notice to the indemnified party that the indemnifying
party disputes in good faith the reasonableness of the unpaid balance of such
fees and expenses.

         (f)      Acknowledgement. The Company, the Selling Stockholder and the
Underwriter agree that, as regards indemnification between the Company and the
Selling Stockholder, notwithstanding anything to the contrary in this Section 6,
and in the event of any conflict between this Section 6 and Section 6 of the
Registration Rights Agreement the provisions of Section 6 of the Registration
Rights Agreement shall control.

         Section 7. Contribution. If the indemnification provided for in Section
6 hereof is for any reason unavailable to or insufficient to hold harmless an
indemnified party in respect of any losses, liabilities, claims, damages or
expenses referred to therein, then each indemnifying party shall contribute to
the aggregate amount of such losses, liabilities, claims, damages and expenses
incurred by such indemnified party, as incurred, (i) in such proportion as is
appropriate to reflect the relative benefits received by the Company and the
Selling Stockholder on the one hand, and the Underwriter on the other hand, from
the offering of the Securities pursuant to this Agreement

                                       21


or (ii) if the allocation provided by clause (i) is not permitted by applicable
law, in such proportion as is appropriate to reflect not only the relative
benefits referred to in clause (i) above but also the relative fault of the
Company and the Selling Stockholder on the one hand, and of the Underwriter on
the other hand, in connection with the statements or omissions which resulted in
such losses, liabilities, claims, damages or expenses, as well as any other
relevant equitable considerations.

         The relative benefits received by the Company and the Selling
Stockholder on the one hand and the Underwriter on the other hand in connection
with the offering of the Securities pursuant to this Agreement shall be deemed
to be in the same respective proportions as the total net proceeds from the
offering of the Securities pursuant to this Agreement (before deducting
expenses) received by each of the Company and the Selling Stockholder and the
total underwriting discount received by the Underwriter, in each case as set
forth on the cover of the Prospectus, bear to the aggregate initial public
offering price of the Securities as set forth on such cover.

         The relative fault of the Company and the Selling Stockholder on the
one hand and the Underwriter on the other hand shall be determined by reference
to, among other things, whether any such untrue or alleged untrue statement of a
material fact or omission or alleged omission to state a material fact relates
to information supplied by the Company or the Selling Stockholder on the one
hand or by the Underwriter on the other hand and the parties' relative intent,
knowledge, access to information and opportunity to correct or prevent such
statement or omission.

         The Company, the Selling Stockholder and the Underwriter agree that it
would not be just and equitable if contribution pursuant to this Section were
determined by pro rata allocation or by any other method of allocation which
does not take account of the equitable considerations referred to above in this
Section. The aggregate amount of losses, liabilities, claims, damages and
expenses incurred by an indemnified party and referred to above in this Section
shall be deemed to include any legal or other expenses reasonably incurred by
such indemnified party in investigating, preparing or defending against any
litigation, or any investigation or proceeding by any governmental agency or
body, commenced or threatened, or any claim whatsoever based upon any such
untrue or alleged untrue statement or omission or alleged omission.

         Notwithstanding the provisions of this Section, the Underwriter shall
not be required to contribute any amount in excess of the amount by which the
total price at which the Securities underwritten by it and distributed to the
public were offered to the public exceeds the amount of any damages which the
Underwriter has otherwise been required to pay by reason of any such untrue or
alleged untrue statement or omission or alleged omission.

         No person guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the 1933 Act) shall be entitled to contribution from any person
who was not guilty of such fraudulent misrepresentation.

         For purposes of this Section, each person, if any, who controls the
Underwriter within the meaning of Section 15 of the 1933 Act or Section 20 of
the 1934 Act shall have the same rights to contribution as the Underwriter, and
each director of the Company or the Selling Stockholder,

                                       22


each officer of the Company who signed either of the Registration Statements,
and each person, if any, who controls the Company or the Selling Stockholder
within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act
shall have the same rights to contribution as the Company or the Selling
Stockholder, as applicable.

                  The provisions of this Section shall not affect any agreement
among the Company and the Selling Stockholder with respect to contribution,
including the agreement in the Registration Rights Agreement.

         Section 8. Representations, Warranties and Agreements to Survive
Delivery. All representations, warranties and agreements contained in this
Agreement or in certificates of officers of the Company or the Selling
Stockholder submitted pursuant hereto shall remain operative and in full force
and effect, regardless of any investigation made by or on behalf of any party
hereto or any controlling person, and shall survive delivery of the Securities
to the Underwriter.

         Section 9. Termination of Agreement.

         (a)      Termination; General. The Underwriter may terminate this
Agreement, by notice to the Company and the Selling Stockholder, at any time at
or prior to Closing Time (i) if there has been, since the time of execution of
this Agreement or since the respective dates as of which information is given in
the Prospectus, any material adverse change in the condition, financial or
otherwise, or in the earnings, business affairs or business prospects of the
Company and its subsidiaries, taken as a whole, whether or not arising in the
ordinary course of business, or (ii) if there has occurred any material adverse
change in the financial markets in the United States or in the international
financial markets, any outbreak of hostilities or escalation thereof or other
calamity or crisis or any change or development involving a prospective change
in national or international political, financial or economic conditions, in
each case the effect of which is such as to make it, in the judgment of the
Underwriter, impracticable to market the Securities or to enforce contracts for
the sale of the Securities, or (iii) if trading in any securities of the Company
has been suspended or materially limited by the Commission or The New York Stock
Exchange, or if trading generally on the American Stock Exchange or the New York
Stock Exchange or in the Nasdaq National Market has been suspended or materially
limited, or minimum or maximum prices for trading have been fixed, or maximum
ranges for prices have been required, by any of said exchanges or by such system
or by order of the Commission, the National Association of Securities Dealers,
Inc. or any other governmental authority, or a material disruption has occurred
in commercial banking or securities settlement or clearance services in the
United States, or (iv) if a banking moratorium has been declared by either
Federal or New York authorities.

         (b)      Liabilities. If this Agreement is terminated pursuant to this
Section, such termination shall be without liability of any party to any other
party except as provided in Section 4 hereof, and provided further that Sections
1, 6, 7 and 8 shall survive such termination and remain in full force and
effect.

         Section 10. Notices. All notices and other communications hereunder
shall be in writing and shall be deemed to have been duly given if mailed or
transmitted by any standard

                                       23


form of telecommunication. Notices to the Underwriter shall be directed to it at
1585 Broadway, New York, New York 10036 attention of Equity Syndicate
Department; notices to the Company shall be directed to it at 1835 Dueber
Avenue, S.W., Canton, Ohio 44706-2798, attention of the Senior Vice President
and General Counsel; and notices to the Selling Stockholder shall be directed to
it at 200 Chestnut Ridge Road, Woodcliff Lake, New Jersey 07677, attention of
Senior Vice President and General Counsel.

         Section 11. Parties. This Agreement shall inure to the benefit of and
be binding upon the Underwriter, the Company and the Selling Stockholder and
their respective successors. Nothing expressed or mentioned in this Agreement is
intended or shall be construed to give any person, firm or corporation, other
than the Underwriter, the Company and the Selling Stockholder and their
respective successors and the controlling persons and officers and directors
referred to in Sections 6 and 7 and their heirs and legal representatives, any
legal or equitable right, remedy or claim under or in respect of this Agreement
or any provision herein contained. This Agreement and all conditions and
provisions hereof are intended to be for the sole and exclusive benefit of the
Underwriter, the Company and the Selling Stockholder and their respective
successors, and said controlling persons and officers and directors and their
heirs and legal representatives, and for the benefit of no other person, firm or
corporation. No purchaser of Securities from the Underwriter shall be deemed to
be a successor by reason merely of such purchase.

         Section 12. GOVERNING LAW AND TIME. THIS AGREEMENT SHALL BE GOVERNED BY
AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. SPECIFIED
TIMES OF DAY REFER TO NEW YORK CITY TIME.

         Section 13. Effect of Headings. The Article and Section headings herein
and the Table of Contents are for convenience only and shall not affect the
construction hereof.

                            [SIGNATURE PAGES FOLLOW]

                                       24


If the foregoing is in accordance with your understanding of our agreement,
please sign and return to the Company and the Selling Stockholder counterparts
hereof, whereupon this instrument, along with all counterparts, will become a
binding agreement among the Underwriter, the Company and the Selling Stockholder
in accordance with its terms.

                              Very truly yours,

                              THE TIMKEN COMPANY

                              By     /s/ Glenn A. Eisenberg
                                 -----------------------------------------------
                              Name: Glenn A. Eisenberg
                              Title: Executive Vice President - Finance and
                              Administration

                              By     /s/ William R. Burkhart
                                 -----------------------------------------------
                              Name: William R. Burkhart
                              Title: Senior Vice President and General Counsel

                              INGERSOLL-RAND COMPANY

                              By     /s/ Timothy R. McLevish
                                 -----------------------------------------------
                              Name: Timothy R. McLevish
                              Title: Senior Vice President and Chief Financial
                              Officer

                              By     /s/ Ronald G. Heller
                                 -----------------------------------------------
                              Name: Ronald G. Heller
                              Title: Vice President and Secretary

CONFIRMED AND ACCEPTED,
as of the date first above written:

MORGAN STANLEY & CO. INCORPORATED

         By   /s/ Trevor Burgess
            --------------------------------------
             Trevor Burgess
             Vice President